以剥脱性龈炎为表现的皮肤疾病诊疗进展

doi:10.3760/cma.j.issn.0412-4030.2019.06.016

中华皮肤科杂志 ›› 2019, Vol. 52 ›› Issue (6): 440-442.doi: 10.3760/cma.j.issn.0412-4030.2019.06.016

• 继续医学教育 • 上一篇

以剥脱性龈炎为表现的皮肤疾病诊疗进展

李锁李志量荆可向睿宇张寒梅冯素英

中国医学科学院北京协和医学院皮肤病医院皮肤科江苏省皮肤病与性病学重点实验室，南京 210042
李锁现在南京医科大学附属常州市第二人民医院皮肤科，江苏常州 213003

发布日期:2019-06-03
通讯作者: 冯素英 E-mail:fengsy@pumcderm.cams.cn
基金资助:
中国医学科学院医学与健康科技创新工程项目（CIFMS?2017-I2M-1-017）

Diagnosis and treatment of skin diseases manifesting as desquamative gingivitis

Li Suo, Li Zhiliang, Jing Ke, Xiang Ruiyu, Zhang Hanmei, Feng Suying

Department of Dermatology, Hospital for Skin Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing 210042, China
Li Suo is working on the Department of Dermatology, Changzhou No.2 People′s Hospital, Affiliated to Nanjing Medical University, Changzhou 213003, Jiangsu, China

Published:2019-06-03
Contact: Feng Suying E-mail:fengsy@pumcderm.cams.cn
Supported by:
CAMS Innovation Fund for Medical Sciences （CIFMS?2017?I2M?1?017）

摘要/Abstract

摘要： 【摘要】以剥脱性龈炎（DG）为表现的皮肤疾病可分为复发性DG和慢性DG相关性皮肤疾病，常见的有口腔扁平苔藓、黏膜性类天疱疮、寻常型天疱疮等。完整的病史、细致的口腔检查及组织病理和血清免疫学检测可帮助我们正确诊断DG相关性皮肤疾病。DG相关性皮肤疾病治疗包括局部治疗和系统治疗，不同疾病及不同患者对药物反应差异较大，需要确定个体化的治疗方案，治疗过程中应加强口腔卫生，避免真菌和细菌继发感染，并注意口腔和牙周组织的保护。

关键词: 牙龈炎；扁平苔藓, 口腔；天疱疮；类天疱疮, 良性黏膜；获得性大疱性表皮松解

Abstract: 【Abstract】 Skin diseases manifesting as desquamative gingivitis （DG） can be divided into recurrent DG? and chronic DG?related skin diseases, including oral lichen planus, mucosal pemphigoid, pemphigus vulgaris and so on. A thorough medical history, detailed oral and histopathological examinations and serum immunological tests can be helpful for correct diagnosis of DG?related skin diseases. The treatment of DG?related skin diseases includes topical and systemic therapies. It is necessary to individualize treatment protocols due to treatment response. During the treatment of DG, oral hygiene should be strengthened, secondary fungal and bacterial infections should be avoided, and attention should be paid to the protection of oral cavity and periodontal tissues.

Key words: Gingivitis, Lichen planus, oral, Pemphigus, Pemphigoid, benign mucous membrane, Epidermolysis bullosa acquisita

李锁李志量荆可向睿宇张寒梅冯素英 . 以剥脱性龈炎为表现的皮肤疾病诊疗进展[J]. 中华皮肤科杂志, 2019,52(6):440-442. doi:10.3760/cma.j.issn.0412-4030.2019.06.016

Li Suo, Li Zhiliang, Jing Ke, Xiang Ruiyu, Zhang Hanmei, Feng Suying . Diagnosis and treatment of skin diseases manifesting as desquamative gingivitis[J]. Chinese Journal of Dermatology, 2019, 52(6): 440-442.doi:10.3760/cma.j.issn.0412-4030.2019.06.016

参考文献 25

［1］	Maderal AD, Lee Salisbury P 3rd, Jorizzo JL. Desquamative gingivitis: clinical findings and diseases［J］. J Am Acad Dermatol, 2018,78（5）:839⁃848. doi: 10.1016/j.jaad.2017.05.056.
［2］	Arduino PG, Broccoletti R, Sciannameo V, et al. A practical clinical recording system for cases of desquamative gingivitis［J］. Br J Dermatol, 2017,177（1）:299⁃301. doi: 10.1111/bjd.15075.
［3］	孟焕新. 牙周病学［M］. 3版. 北京: 人民卫生出版社, 2008:93⁃95.
［4］	Karagoz G, Bektas⁃Kayhan K, Unur M. Desquamative gingivitis: a review［J］. J Istanb Univ Fac Dent, 2016,50（2）:54⁃60. doi: 10.17096/jiufd.57228.
［5］	Al⁃Abeedi F, Aldahish Y, Almotawa Z, et al. The differential diagnosis of desquamative gingivitis: review of the literature and clinical guide for dental undergraduates［J］. J Int Oral Health, 2015,7（Suppl 1）:88⁃92.
［6］	Arduino PG, Romano F, Sasia D, et al. Subgingival microbiota in white patients with desquamative gingivitis: a cross⁃sectional study［J］. J Periodontol, 2017,88（7）:643⁃650. doi: 10.1902/jop. 2017.160745.
［7］	Elsaadany BA, Ahmed EM, Aghbary S. Efficacy and safety of topical corticosteroids for management of oral chronic graft versus host disease［J］. Int J Dent, 2017,2017:1908768. doi: 10.1155/2017/1908768.
［8］	Kiran MS, Vidya S, Aswal GS, et al. Systemic and topical steroids in the management of oral mucosal lesions［J］. J Pharm Bioallied Sci, 2017,9（Suppl 1）:S1⁃1S3. doi: 10.4103/jpbs. JPBS_91_17.
［9］	Davari P, Hsiao HH, Fazel N. Mucosal lichen planus: an evidence⁃based treatment update［J］. Am J Clin Dermatol, 2014,15（3）:181⁃195. doi: 10.1007/s40257⁃014⁃0068⁃6.
［10］	Mirza S, Rehman N, Alrahlah A, et al. Efficacy of photodynamic therapy or low level laser therapy against steroid therapy in the treatment of erosive⁃atrophic oral lichen planus［J］. Photodiagnosis Photodyn Ther, 2018,21:404⁃408. doi: 10.1016/j.pdpdt.2018.02.001.
［11］	Kechichian E, Ingen⁃Housz⁃Oro S, Sbidian E, et al. A large epidemiological study of erythema multiforme in France, with emphasis on treatment choices［J］. Br J Dermatol, 2018,179（4）:1009⁃1011. doi: 10.1111/bjd.16928.
［12］	Nogueira PA, Carneiro S, Ramos⁃e⁃Silva M. Oral lichen planus: an update on its pathogenesis［J］. Int J Dermatol, 2015,54（9）:1005⁃1010. doi: 10.1111/ijd.12918.
［13］	Esatoglu SN, Hatemi G, Leccese P, et al. Highlights of the 17th international conference on Behçet′s syndrome［J］. Clin Exp Rheumatol, 2016,34（6 Suppl 102）:3⁃9.
［14］	Olson MA, Rogers RS 3rd, Bruce AJ. Oral lichen planus［J］. Clin Dermatol, 2016,34（4）:495⁃504. doi: 10.1016/j.clindermatol.2016. 02.023.
［15］	Joly P, Maho⁃Vaillant M, Prost⁃Squarcioni C, et al. First⁃line rituximab combined with short⁃term prednisone versus prednisone alone for the treatment of pemphigus （Ritux 3）: a prospective, multicentre, parallel⁃group, open⁃label randomised trial［J］. Lancet, 2017,389（10083）:2031⁃2040. doi: 10.1016/S0140⁃6736（17）30070⁃3.
［16］	Schmidt E. Rituximab as first⁃line treatment of pemphigus［J］. Lancet, 2017,389（10083）:1956⁃1958. doi: 10.1016/S0140⁃6736（17）30787⁃0.
［17］	Zhang C, Goldscheider I, Ruzicka T, et al. Pemphigus vulgaris persistently localized to the nose with local and systemic response to topical steroids［J］. Acta Derm Venereol, 2017,97（9）:1136⁃1137. doi: 10.2340/00015555⁃2725.
［18］	周生儒, 邹雅茹, 刘芝翠, 等. 天疱疮患者皮损局部异位淋巴结构的病理学特征［J］. 中华皮肤科杂志, 2018,51（1）:20⁃25. doi: 10.3760/cma.j.issn.0412⁃4030.2018.01.005.
［19］	李静, 朱学骏. 副肿瘤性天疱疮的基础与临床研究［J］. 中国医学科学院学报, 2009,31（5）:654⁃658. doi: 10.3881/j.issn.1000⁃503X.2009.05.032.
［20］	张燕, 潘萌. 副肿瘤性天疱疮11例分析［J］. 中华皮肤科杂志, 2014,47（10）:715⁃718. doi: 10.3760/cma.j.issn.0412⁃4030.2014. 10.009.
［21］	Vijayan V, Paul A, Babu K, et al. Desquamative gingivitis as only presenting sign of mucous membrane pemphigoid［J］. J Indian Soc Periodontol, 2016,20（3）:340⁃343. doi: 10.4103/0972⁃124X.182602.
［22］	Cozzani E, Di Zenzo G, Calabresi V, et al. Autoantibody profile of a Cohort of 78 Italian patients with mucous membrane pemphigoid: correlation between reactivity profile and clinical involvement［J］. Acta Derm Venereol, 2016,96（6）:768⁃773. doi: 10.2340/00015555⁃2311.
［23］	Sultan AS, Villa A, Saavedra AP, et al. Oral mucous membrane pemphigoid and pemphigus vulgaris⁃a retrospective two⁃center cohort study［J］. Oral Dis, 2017,23（4）:498⁃504. doi: 10.1111/odi.12639.
［24］	Maley A, Warren M, Haberman I, et al. Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid （MMP）［J］. J Am Acad Dermatol, 2016,74（5）:835⁃840. doi: 10.1016/j.jaad. 2016.01.020.
［25］	Nishida E, Nishio E, Murashima H, et al. Case of epidermolysis bullosa acquisita with concomitant anti⁃laminin⁃332 antibodies［J］. J Dermatol, 2018,45（4）:472⁃474. doi: 10.1111/1346⁃8138. 14169.

以剥脱性龈炎为表现的皮肤疾病诊疗进展

Diagnosis and treatment of skin diseases manifesting as desquamative gingivitis

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 25

相关文章 0

Metrics

本文评价

推荐阅读 10